58 209

Cited 5 times in

Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)

DC Field Value Language
dc.contributor.author박준성-
dc.contributor.author이우정-
dc.date.accessioned2022-09-14T01:44:38Z-
dc.date.available2022-09-14T01:44:38Z-
dc.date.issued2021-11-
dc.identifier.issn1976-2283-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/190594-
dc.description.abstractBackground/aims: Several prediction models for evaluating the prognosis of nonmetastatic resected pancreatic ductal adenocarcinoma (PDAC) have been developed, and their performances were reported to be superior to that of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system. We developed a prediction model to evaluate the prognosis of resected PDAC and externally validated it with data from a nationwide Korean database. Methods: Data from the Surveillance, Epidemiology and End Results (SEER) database were utilized for model development, and data from the Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP) database were used for external validation. Potential candidate variables for model development were age, sex, histologic differentiation, tumor location, adjuvant chemotherapy, and the AJCC 8th staging system T and N stages. For external validation, the concordance index (C-index) and time-dependent area under the receiver operating characteristic curve (AUC) were evaluated. Results: Between 2004 and 2016, data from 9,624 patients were utilized for model development, and data from 3,282 patients were used for external validation. In the multivariate Cox proportional hazard model, age, sex, tumor location, T and N stages, histologic differentiation, and adjuvant chemotherapy were independent prognostic factors for resected PDAC. After an exhaustive search and 10-fold cross validation, the best model was finally developed, which included all prognostic variables. The C-index, 1-year, 2-year, 3-year, and 5-year time-dependent AUCs were 0.628, 0.650, 0.665, 0.675, and 0.686, respectively. Conclusions: The survival prediction model for resected PDAC could provide quantitative survival probabilities with reliable performance. External validation studies with other nationwide databases are needed to evaluate the performance of this model.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherEditorial Office of Gut and Liver-
dc.relation.isPartOfGUT AND LIVER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHCarcinoma, Pancreatic Ductal* / pathology-
dc.subject.MESHHumans-
dc.subject.MESHNeoplasm Staging-
dc.subject.MESHPancreas / pathology-
dc.subject.MESHPancreatic Neoplasms* / epidemiology-
dc.subject.MESHPancreatic Neoplasms* / pathology-
dc.subject.MESHPrognosis-
dc.subject.MESHRegistries-
dc.subject.MESHRepublic of Korea / epidemiology-
dc.titleDevelopment and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학교실)-
dc.contributor.googleauthorJae Seung Kang-
dc.contributor.googleauthorLydia Mok-
dc.contributor.googleauthorJin Seok Heo-
dc.contributor.googleauthorIn Woong Han-
dc.contributor.googleauthorSang Hyun Shin-
dc.contributor.googleauthorYoo-Seok Yoon-
dc.contributor.googleauthorHo-Seong Han-
dc.contributor.googleauthorDae Wook Hwang-
dc.contributor.googleauthorJae Hoon Lee-
dc.contributor.googleauthorWoo Jung Lee-
dc.contributor.googleauthorSang Jae Park-
dc.contributor.googleauthorJoon Seong Park-
dc.contributor.googleauthorYonghoon Kim-
dc.contributor.googleauthorHuisong Lee-
dc.contributor.googleauthorYoung-Dong Yu-
dc.contributor.googleauthorJae Do Yang-
dc.contributor.googleauthorSeung Eun Lee-
dc.contributor.googleauthorIl Young Park-
dc.contributor.googleauthorChi-Young Jeong-
dc.contributor.googleauthorYounghoon Roh-
dc.contributor.googleauthorSeong-Ryong Kim-
dc.contributor.googleauthorJu Ik Moon-
dc.contributor.googleauthorSang Kuon Lee-
dc.contributor.googleauthorHee Joon Kim-
dc.contributor.googleauthorSeungyeoun Lee-
dc.contributor.googleauthorHongbeom Kim-
dc.contributor.googleauthorWooil Kwon-
dc.contributor.googleauthorChang-Sup Lim-
dc.contributor.googleauthorJin-Young Jang-
dc.contributor.googleauthorTaesung Park-
dc.identifier.doi10.5009/gnl20306-
dc.contributor.localIdA01672-
dc.contributor.localIdA02993-
dc.relation.journalcodeJ00954-
dc.identifier.eissn2005-1212-
dc.identifier.pmid33941710-
dc.subject.keywordPancreatic neoplasms-
dc.subject.keywordPrognosis-
dc.subject.keywordSurvival-
dc.contributor.alternativeNamePark, Joon Seong-
dc.contributor.affiliatedAuthor박준성-
dc.contributor.affiliatedAuthor이우정-
dc.citation.volume15-
dc.citation.number6-
dc.citation.startPage912-
dc.citation.endPage921-
dc.identifier.bibliographicCitationGUT AND LIVER, Vol.15(6) : 912-921, 2021-11-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.